The opinion in support of the decision being entered today
is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte WENDY MAURY, JACK STAPLETON, RICHARD ROLLER,
MARK STINSKI, PAUL B. MCCRAY, and BRIAN TACK
__________
Appeal 2007-1621
Application 10/721,839
Technology Center 1600
__________
Decided: July 24, 2007
__________
Before TONI R. SCHEINER, DONALD E. ADAMS, and ERIC GRIMES,
Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 involving claims to reducing
the infectivity of a virus by administering a chimeric theta defensin peptide.
The Examiner has rejected the claims as obvious. We have jurisdiction
under 35 U.S.C. § 6(b). We affirm.
BACKGROUND
“Antimicrobial peptides have been isolated from plants, insects, fish,
amphibia, birds, and mammals. Although previously considered an
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: September 9, 2013